Zacks Investment Research downgraded shares of Trupanion Inc (NYSE:TRUP) from a buy rating to a hold rating in a research report released on Friday morning.
According to Zacks, “Trupanion, Inc. operates as a direct-to-consumer monthly subscription service provider of a medical insurance plan for cats and dogs. It operates primarily in Canada, Puerto Rico, and the United States. The Company serves pet owners and veterinarians. Trupanion, Inc. is headquartered in Seattle, Washington. “
A number of other analysts also recently issued reports on the company. RBC Capital Markets set a $18.00 price target on Trupanion and gave the stock a buy rating in a report on Tuesday, September 20th. Stifel Nicolaus lifted their price target on Trupanion from $17.00 to $20.00 and gave the stock a buy rating in a report on Wednesday, August 3rd. Finally, Canaccord Genuity reaffirmed a buy rating and set a $19.00 price target on shares of Trupanion in a report on Thursday, August 4th. Two analysts have rated the stock with a hold rating and six have given a buy rating to the company. The stock has an average rating of Buy and a consensus target price of $16.00.
Trupanion (NYSE:TRUP) opened at 16.73 on Friday. The stock has a 50 day moving average price of $16.14 and a 200-day moving average price of $15.20. The firm’s market capitalization is $489.40 million. Trupanion has a one year low of $7.61 and a one year high of $17.68.
Trupanion (NYSE:TRUP) last released its earnings results on Tuesday, November 1st. The company reported ($0.06) earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of ($0.06). The company earned $48.40 million during the quarter, compared to analysts’ expectations of $48.17 million. The company’s revenue for the quarter was up 27.7% on a year-over-year basis. During the same quarter last year, the business posted ($0.17) earnings per share. On average, analysts predict that Trupanion will post ($0.23) earnings per share for the current fiscal year.
In related news, Director Howard E. Rubin sold 21,379 shares of the business’s stock in a transaction dated Tuesday, August 30th. The stock was sold at an average price of $14.95, for a total value of $319,616.05. Following the transaction, the director now owns 146,579 shares in the company, valued at approximately $2,191,356.05. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Howard E. Rubin sold 75,000 shares of the business’s stock in a transaction dated Monday, October 3rd. The shares were sold at an average price of $16.56, for a total value of $1,242,000.00. Following the completion of the transaction, the director now owns 100,000 shares in the company, valued at approximately $1,656,000. The disclosure for this sale can be found here.
A number of institutional investors have recently modified their holdings of the stock. Hamilton Lane Advisors LLC acquired a new stake in shares of Trupanion during the second quarter worth $1,657,000. Monashee Investment Management LLC acquired a new stake in shares of Trupanion during the second quarter worth $245,000. RMB Capital Management LLC acquired a new stake in shares of Trupanion during the second quarter worth $1,642,000. Emerald Acquisition Ltd. acquired a new stake in shares of Trupanion during the second quarter worth $529,000. Finally, California Public Employees Retirement System raised its stake in shares of Trupanion by 80.4% in the second quarter. California Public Employees Retirement System now owns 45,100 shares of the company’s stock worth $598,000 after buying an additional 20,100 shares in the last quarter.
Trupanion Company Profile
Trupanion, Inc provides a medical insurance plan for cats and dogs across the United States, Canada and Puerto Rico. The Company operates through two segments: subscription business and other business. The subscription business segment includes monthly subscriptions related to the Company’s medical plan, which are marketed directly to consumers.